Du är här


Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 May 2014

Bagsvaerd, Denmark, 2 May 2014
In accordance with Section 28a of the Danish Securities Trading Act, the
company's board members and executives have given Novo Nordisk power of
attorney on their behalf to publish trading in Novo Nordisk shares by the
company's board members, executives and their associated persons as reported
by those persons to Novo Nordisk.

Further information-------------------------------------------------------------------
|Media: |
|Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com |
|Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com |
| |
|Investors: |
|Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com |
|Jannick Lindegaard Denholt +45 3079 8519 jlis@novonordisk.com |
|Lars Borup Jacobsen +45 3075 3479 lbpj@novonordisk.com |
|Daniel Bohsen +45 3079 6376 dabo@novonordisk.com |
|Frank Daniel Mersebach (US) +1 609 235 8567 fdni@novonordisk.com |
Company announcement No 30 / 2014

Company Announcement No 30 2014


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.